The evolution of liver transplantation practices

Current Opinion in Organ Transplantation

Volumn 13, Issue 3, 2008, Pages 275-279

  Walia, Ann ^a   Schumann, Roman ^b,c  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TUFTS MEDICAL CENTER   (United States)

Author keywords

Anesthetic management of liver transplantation; Evolution of perioperative care; Fast tracking in liver transplantation; History of liver transplantation; Model for end stage liver disease

Indexed keywords

ANTIFIBRINOLYTIC AGENT; APROTININ; CISATRACURIUM; DESFLURANE; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

BLEEDING; BLOOD COMPONENT THERAPY; CLINICAL PRACTICE; CLINICAL TRIAL; DISEASE FREE SURVIVAL; EXTUBATION; HEALTH CARE COST; HEART DEATH; HEMOSTASIS; HISTORY OF MEDICINE; HUMAN; LIVER DISEASE; LIVER TRANSPLANTATION; LIVING DONOR; OUTCOME ASSESSMENT; PATIENT SELECTION; PERIOPERATIVE PERIOD; REVIEW; UNITED STATES; ANESTHESIA; ENDOTRACHEAL INTUBATION; TRANSPLANTATION;

ANESTHESIA; BLOOD LOSS, SURGICAL; HUMANS; INTUBATION, INTRATRACHEAL; LIVER TRANSPLANTATION; PERIOPERATIVE CARE; TISSUE AND ORGAN PROCUREMENT;

EID: 54549120298     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e3282ffabee     Document Type: Review

References (57)

1. Guild WR, Harrison JH, Merrill JP, Murray J. Successful homotransplantation of the kidney in an identical twin. Trans Am Clin Climatol Assoc 1955; 67:167-173.
2. Starzl TE, Marchioro TL, Von Kaulla KN, et al. Homotransplantation of the liver in humans. Surg Gynecol Obstet 1963; 117:659-676.
3. Starzl TE, Marchioro TL, Porter KA, Brettschneider L. Homotransplantation of the liver. Transplantation 1967; 5 (Suppl):790-803.
4. Aldrete JA, LeVine DS, Gingrich TF. Experience in anesthesia for liver transplantation. Anesth Analg 1969; 48:802-814.
5. Kang Y. A Message from Dr. Kang, Founding President of ILTS: Welcome to the new ILTS Web Site. International Liver Transplant Society. http://www. ilts.org/about.cfm. [Accessed 5 November 2007].
6. Berkowitz M. History of the International Liver Transplantation Society. Liver Transpl 2003; 9:1124-1127.
7. Shaw BW Jr, Martin DJ, Marquez JM, et al. Venous bypass in clinical liver transplantation. Ann Surg 1984; 200:524-534.
8. Tzakis A, Todo S, Starzl TE. Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg 1989; 210:649-652.
9. Figueras J, Llado L, Ramos E, et al. Temporary portocaval shunt during liver transplantation with vena cava preservation. Results of a prospective randomized study. Liver Transpl 2001; 7:904-911.
10. United Network for Organ Sharing. http://www.unos.org. [Accessed 11 November 2007].
11. Mandell MS, Hendrickse A. Donation after cardiac death. Curr Opin Organ Transplant 2007; 12:298-302.
12. Renz JF, Yersiz H, Reichert PR, et al. Split-liver transplantation: A review. Am J Transplant 2003; 3:1323-1335.
13. Broelsch CE, Whitington PF, Emond JC, et al. Liver transplantation in children from living related donors. Surgical techniques and results. Ann Surg 1991; 214:428-437.
14. Todo S, Furukawa H, Jin MB, Shimamura T. Living donor liver transplantation in adults: outcome in Japan. Liver Transpl 2000; 6 (Suppl 2):S66-S72.
15. Marcos A, Fisher RA, Ham J, et al. Right lobe living donor liver transplantation. Transplantation 1999; 68:798-803.
16. Pietsch UC, Schaffranietz L. Anaesthesiological management in orthotopic liver transplantation: results of survey. Anesthesiol Intensivmed Notfallmed Schmerzther 2006; 41:21-26. This is an interesting recent assessment of differences in perioperative anesthetic management of liver transplantation in one country.
17. Schumann R. Intraoperative resource utilization in anesthesia for liver transplantation in the United States: a survey. Anesth Analg 2003; 97:21-28.
18. Trotter JF. Impact of the model for endstage liver disease score on liver transplantation. Curr Opinion Organ Transplant 2007; 12:294-297. This is a good review on the impact of adaptation of MELD allocation system not only on pretransplant mortality but also on the organ availability in different regions. It also highlights areas that need to be addressed to make the MELD system of organ allocation more effective and equitable.
19. Department of Health and Human Services. Organ donation and utilization in the United States, 1996-2005: Deceased organ distribution. OPTN/SRTR Annual Report. http://www.optn.org/ar2006/chapter-ii-AR-cd.htm#2. [Accessed 5 November 2007].
20. Merion RM, Schaubel DE, Dykstra DM, et al. The survival benefit of liver transplantation. Am J Transplant 2005; 5:307-313.
21. The OPTN/SRTR Annual Report. Scientific Registry of Transplant Recipients. Ustransplant. http://www.ustransplant.org/annual-Reports/default. aspx. [Accessed 18 February 2008].
22. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334:693-699.
23. Freeman RB, Edwards EB, Harper AM. Waiting list removal rates among patients with chronic and malignant liver disease. Am J Transplant 2006; 6:1416-1421. This is an excellent review of the impact of MELD on pretransplant mortality and the addition of adjusted MELD on organ allocation.
24. Young AL, Rajagenashan R, Asthana S. The value of MELD and sodium in assessing potential liver transplant recipients in the United Kingdom [Erratum in Transpl Int 2007; 20:565]. Transpl Int 2007; 20:331-337. This article gives a good perspective on the use of MELD and delta MELD in conjunction with serum sodium levels in predicting pretransplant mortality in the UK where organ allocation is not based on MELD.
25. Biggins SW, Rodriguez HJ, Bacchetti P, et al. Serum Sodium predicts mortality in patients listed for liver transplantation. Hepatology 2005; 41:32-39.
26. Said A, Einstein M, Lucey MR. Liver transplantation: an update 2007. Cur Opin Gastroenterol 2007; 23:292-298. This is an excellent summary on definition and calculation of MELD as well as outcomes for patients undergoing liver transplantation for various etiologies of liver failure.
27. de Boer MT, Molenaar IQ, Hendriks HGD, et al. Minimizing blood loss in liver transplantation: progress through research and techniques. Dig Surg 2005; 22:265-275.
28. Massicotte L, Lenis S, Thibeault L, et al. Effect of low central venous pressure and phlebotomy on blood product transfusion requirements during liver transplantation. Liver Transpl 2006; 12:117-123. This thought-provoking paper describes an aggressive approach to reducing transfusion requirements during liver transplantation in a single center.
29. Ozier Y, Passione F, Samain E, Courtois F, French Study Group on Blood Transfusion in Liver Transplantation. Institutional variability in transfusion practice for liver transplantation. Anesth Analg 2003; 97:671-679.
30. Jovine E, Mazziotti A, Grazi GL, Ercolani G, et al. Piggy-back versus conventional technique in liver transplantation: report of a randomized trial. Transpl Int 1997; 10:109-112.
31. Miyamoto S, Polak WG, Geuken E, et al. Liver transplantation with preservation of the inferior vena cava. A comparison of conventional and piggyback techniques in adults. Clin Transplant 2004; 18:686-693.
32. Jones RM, Moulton CE, Hardy KJ. Central venous pressure and its effect on blood loss during liver resection. Br J Surg 1998; 85:1058-1060; .
33. Shore-Lesserson L, Manspeizer HE, DePerio M, et al. Thromboelastographyguided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg 1999; 88:312-319.
34. Kang YG, Martin DJ, Marquez J, et al. Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Anesth Analg 1985; 64:888-896.
35. Lerner AB, Sundar E, Mahmood F, et al. Four cases of cardiopulmonary thromboembolism during liver transplantation without the use of antifibrinolytic drugs. Anesth Analg 2005; 101:1608-1612.
36. Molenaar IQ, Warnaar N, Groen H, et al. Efficacy and safety of anitifibrinolytic drugs in liver transplantation: a systematic review and meta-analysis. Am J Transplant 2007; 7:185-194. This is an excellent evidence-based meta-analysis on the risks and benefits of antifibrinolytics during liver transplantation.
37. Porte RJ, Molenaar IQ, Begliomini B, et al. Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised doubleblind study. Lancet 2000; 355:1303-1309.
38. Molenaar IQ, Begliomini B, Grazi GL, et al. The effect of aprotinin on renal function in orthotopic liver transplantation. Transplantation 2001; 71:247- 252.
39. Molenaar IQ, Veldman M, Begliomini B, et al. Improved early graft survival in patients reciving aprotinin during orthotopic liver transplantation. Transplant Proc 2001; 33:1345-1346.
40. Dalmau A, Sabate A, Koo M, et al. The prophylactic use of tranexamic acid and aprotinin in orthotopic liver transplantation: a comparative study. Liver Transpl 2004; 10:279-284.
41. Food and Drug Administration. FDA requests marketing suspension of trasylol. http://www.fda.gov/bbs/topics/NEWS/2007/NEW01738.html. [Accessed 5 November 2007].
42. Gibbs NM. The place of recombinant activated factor VII in liver transplantation. Int Anesthesiol Clin 2006; 44:99-110. This excellent monograph discusses the current utility of recombinant factor VIIa in liver transplantation and questions to be solved.
43. Rossaint R, Slama K, Jaeger M, et al. Fluid restriction and early extubation for successful liver transplantation. Transplant Proc 1990; 22:1533-1534.
44. Plevak DJ, Torsher LC. Fast tracking in liver transplantation. Liver Transpl Surg 1997; 3:447-448.
45. Ferraz-Neto BH, Silva ED, Afonso RC, et al. Early extubation in liver transplantation. Transplant Proc 1999; 31:3067-3068.
46. Biancofiore G, Romanelli AM, Bindi ML, et al. Very early tracheal extubation without predetermined criteria in a liver transplant recipient population. Liver Transpl 2001; 7:777-782.
47. Ulukaya S, Ayanoglu HO, Acar L, et al. Immediate tracheal extubation of the liver transplant recipients in the operating room. Transplant Proc 2002; 34:3334-3335.
48. Glanemann M, Busch T, Neuhaus P, Kaisers U. Fast tracking in liver transplantation. Immediate postoperative tracheal extubation: feasibility and clinical impact. Swiss Med Wkly 2007; 137:187-191. This paper provides a broad review of issues and benefits related to fast-tracking in liver transplantation.
49. Mandell MS, Lezotte D, Kam I, Zamudio S. Reduced use of intensive care after liver transplantation: influence of early extubation. Liver Transpl 2002; 8:676- 681.
50. Mandell MS, Lezotte D, Kam I, Zamudio S. Reduced use of intensive care after liver transplantation: patient attributes that determine early transfer to surgical wards. Liver Transpl 2002; 8:682-687.
51. Biancofiore G, Bindi ML, Romanelli AM, et al. Fast track in liver transplantation: 5 years' experience. Eur J Anesthesiol 2005; 22:584-590.
52. Neelakanta G, Sopher M, Chan S, et al. Early tracheal extubation after liver transplantation. J Cardiothorac Vasc Anesth 1997; 11:165-167.
53. Mandell MS, Lockrem J, Kelley SD. Immediate tracheal extubation after liver transplantation: experience of two transplant centers. Anesth Analg 1997; 84:249-253.
54. Glanemann M, Langrehr J, Kaisers U, et al. Postoperative tracheal extubation after orthotopic liver transplantation. Acta Anaesthesiol Scand 2001; 45:333-339.
55. Glanemann M, Hoffmeister R, Neumann U, et al. Fast tracking in liver transplantation: which patient benefits from this approach? Transplant Proc 2007; 39:535-536.
56. Salizzoni M, Cerutti E, Romagnoli R, et al. The first one thousand liver transplants in Turin: a single-center experience in Italy. Transpl Int 2005; 18:1328-1335.
57. Mandell MS, Stoner TJ, Barnett R, et al. A multicenter evaluation of safety of early extubation in liver transplant recipients. Liver Transpl 2007; 13:1557- 1563. This article reports results of a rare prospective multicenter effort to scientifically evaluate feasibility of early extubation following liver transplantation.